Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Intensive Care Medicine
Erschienen in: Intensive Care Medicine 5/2003

01.05.2003 | Review

The impact of critical care pharmacists on enhancing patient outcomes

verfasst von: Sandra L. Kane, Robert J. Weber, Joseph F. Dasta

Erschienen in: Intensive Care Medicine | Ausgabe 5/2003

Einloggen, um Zugang zu erhalten

Abstract

The highly specialized knowledge and skills needed to care for critically ill patients requires a multidisciplinary team approach. Pharmacists are integral members of this team. They make valuable contributions to improve clinical, economic, and humanistic outcomes of patients. The purpose of this article is to review the literature pertaining to pharmacists' contributions within a multidisciplinary intensivist-led intensive care unit (ICU) team. Pharmacist interventions include correcting/clarifying orders, providing drug information, suggesting alternative therapies, identifying drug interactions, and therapeutic drug monitoring. Pharmacist involvement in improving clinical outcomes of critically ill patients is associated with optimal fluid management and substantial reductions in the rates of adverse drug events, medication administration errors, and ventilator-associated pneumonia. Furthermore, economic evaluations of clinical pharmacy services in the ICU consistently reveal the potential for considerable cost savings.
Literatur
1.
Ferdinande P (1997) Recommendation on minimal requirements for intensive care departments. Intensive Care Med 23:226–232CrossRefPubMed
2.
Pronovost PJ, Angus DC, Dorman T, Robinson KA, Dremsizov TT, Young TL (2002) Physician staffing patterns and clinical outcomes in critically ill patients: a systemic review. JAMA 288:2151–2162CrossRefPubMed
3.
Kaye J, Ashline V, Erickson D, Zeiler K, Gavigan D, Gannon L, Wynne P, Cooper J, Kittle W, Sharma K, Morton J (2000) Critical care bug team: a multi-disciplinary team approach to reducing ventilator-associated pneumonia. Am J Infection Control 28:197–201CrossRef
4.
Henneman E, Dracup K, Ganz T, Molayeme O, Cooper CB (2002) Using a collaborative weaning plan to decrease duration of mechanical ventilation and length of stay in the intensive care unit for patients receiving long-term ventilation. Am J Crit Care 11:132–140PubMed
5.
Stenger K, Schooley K, Moss L (2001) Moving to evidence-based practice for pain management in the critical care setting. Crit Care Nurs Clin North Am 13:319–327CrossRefPubMed
6.
Bjornson DC, Hiner WO, Potyk RP, Nelson BA, Lombardo FA, Morton TA, Larson LV, Martin BP, Sikora RG, Cammarata FA (1993) Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 50:1875–1884PubMed
7.
Devlin JW, Holbrook AM, Fuller HD (1997) The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost. Ann Pharmacotherapy 31:689–695CrossRef
8.
Dasta JF (1996) Evolving role of the pharmacist in the critical care environment J Clin Anesth 8:99S-102SPubMed
9.
Kilroy RA, Iafrate R (1993) Provision of pharmaceutical care in the intensive care unit. Crit Care Nurs Clinics North Am 5:221–225CrossRef
10.
Dasta JF, Segal R, Cunningham A (1989) National survey of critical-care pharmaceutical services. Am J Hosp Pharm 46:2308–2312PubMed
11.
Hahn K, Marlowe K, Chicella M (2001) Survey of pharmaceutical services in pediatric resuscitation. Am J Hosp Pharm 58:1626–1628
12.
Madhavan SS, Rosenbluth SA, Amonkar M, Borker RD, Richards T (2001) Pharmacists and immunizations: a national survey. J Am Pharm Assoc 41:32–45
13.
Monaghan MJ, Monaghan MS (1998) Are pharmacists and pharmaceutical care having an impact on diabetes? Pharm Pract Manage Q 17:8–16
14.
Pedersen CA, Schneider PJ, Santell JP, Kelly EJ (2000) ASHP national survey of pharmacy practice in acute care settings: monitoring, patient education and wellness-2000. Am J Health Sys Pharm 57:2171–2187CrossRef
15.
Rignold DJ, Santell JP, Schneider PJ (2000) ASHP national survey of pharmacy practice in acute care settings: dispensing and administration-1999. Am J Health Sys Pharm 57:1759–1775CrossRef
16.
Rudis MI, Brandl KM, SCCM/ACCP Task Force (2000) Position paper on critical care pharmacy services. Crit Care Med 28:3746–3750CrossRefPubMed
17.
Society of Critical Care Medicine and American College of Clinical Pharmacy (2000) Position paper on critical care pharmacy services. Pharmacotherapy 20:1400–1406CrossRef
18.
Hatoum HT, Hutchinson RA, Witte KW, Newby GY (1988) Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction. Drug Intell Clin Pharm 22:252–259CrossRefPubMed
19.
Bond CA, Raehl CL, Franke T (1999) Clinical pharmacy services and hospital mortality rates. Pharmacotherapy 19:556–564CrossRefPubMed
20.
Bond CA, Raehl CL, Franke T (2001) Interrelationships among mortality rates, drug costs, total cost of care and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing. Pharmacotherapy 21:129–141CrossRefPubMed
21.
Rubenfeld GD, Angus DC, Pinsky J (1999) Outcomes research in critical care. Am J Respir Crit Care Med 160:358–367CrossRefPubMed
22.
Kozma CM, Reeder CE, Schulz RM (1993) Economic, clinical and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther 15:1121–1132PubMed
23.
Calabrese AD, Erstad BL, Brandl K, Barletta J, Kane SL, Sherman DS (2001) Medication administration errors in adult patients in the ICU. Intensive Care Med 27:1592–1598CrossRefPubMed
24.
Rudis MI, Sikora CA, Angus E, Peterson E, Popovich J, Hyzy R, Zarowitz BJ (1997) A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med 25:575–583CrossRefPubMed
25.
Lavny S, Hammerman A, Shani S, Shemer J (2000) Israel hospital pharmaceutical services: a national survey. Harefuah 138:828–831
26.
Cotter SM, Barber ND, McKee M (1994) Survey of clinical pharmacy services in United Kingdom National Health Service hospitals. Am J Hosp Pharm 51:2676–2684PubMed
27.
Boyko WL, Yurkowski PJ, Ivey MF, Marianne F. Ivey, Armitstead JA, Roberts BL (1997) Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health-Syst Pharm 54:1591–1595
28.
Broyles JE, Brown RO, Vehe KL, Nolly RJ, Luther W (1991) Pharmacist interventions impove fluid balance in fluid-restricted patients requiring parenteral nutrition. DICP 25:119–122CrossRefPubMed
29.
Hatton J (1992) Multidisciplinary drug-use for stress ulcer prophylaxis. Am J Hosp Pharm 49:1440–1444PubMed
30.
Tierney M, Carter-Snell C, Cardinal P, Baxter A (1996) Comparison of duration of mechanical ventilation and cost associated with midazolam and lorazepam infusions in critically ill patients. Can J Hosp Pharm 49:211–215
31.
Hadbavny AM, Hoyt JW (1993) Promotion of cost-effective benzodiazepine sedation. Am J Hosp Pharm 50:60–61
32.
Kane SL, Gerlach AT, Cook CH, Essig G, Dasta JF (2001) Variation of bispectral index (BIS) values in chemically paralyzed patients. Pharmacotherapy 21:369CrossRef
33.
Zarowitz BJ, Rudis MI, Lai K, Petitta A, Lulek M (1997) Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patients. Pharmacotherapy 17:327–332PubMed
34.
Rudis MI, Guslits BJ, Peterson EL, Hathaway SJ, Angus E, Beis S, Zarowitz BJ (1996) Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit. Crit Care Med 24:1749–1756CrossRefPubMed
35.
Dager WE, Alberson TE (1992) Impact of therapeutic drug monitoring of intravenous theophylline regimens on serum theophylline concentrations in the medical intensive care unit. Ann Pharmacotherapy 26:1287–1291CrossRef
36.
Streetman DS, Nafziger AN, Destache CJ, Bertino JS (2001) Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs. Pharmacotherapy 21:443–451CrossRefPubMed
37.
Leape LL, Cullen DJ, Dempsey Clapp M, Burdick M, Demonaco HJ, Erickson JI, Bates DW (1999) Pharmacist participation on physician rounds and adverse events in the intensive care unit. JAMA 282:267–270CrossRefPubMed
38.
Tissot E, Cornette C, Demoly P, Jacquet M, Barale F, Capellier G (1999) Medication errors at the administration phase in an intensive care unit. Intensive Care Med 25:353–359CrossRefPubMed
39.
Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections. Chest 115:462–474CrossRefPubMed
40.
Klem C, Dasta JF (1996) Efforts of pharmacy to reduce antibiotic resistance. New Horiz 4:377–384PubMed
41.
Ibrahim KH, Gunderson B, Rotschafer JC (2001) Intensive care unit antimicrobial resistance and the role of the pharmacist. Crit Care Med 29 [Suppl]:N108-N113
42.
Weber RJ, Kane SL, Oriolo VA, Saul M, Skledar SJ, Dasta JF (2003) The impact of ICU drug use on hospital costs: a descriptive analysis with recommendations for optimizing ICU pharmacotherapy. Crit Care Med 31:s17-s24CrossRefPubMed
43.
Sznajder M, Aegerter M, Launois Merliere Y, Guidet B, CubRea (2001) A cost-effectiveness analysis of stays in intensive care units. Intensive Care Med 27:146–153CrossRefPubMed
44.
Chaung LC, Sutton JD, Henderson GT (1994) Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit. Hosp Pharm 29:215–218
45.
Singer M, Myers S, Hall G, Cohen SL, Armstrong RF (1994) The cost of intensive care: a comparison on one unit between 1988 and 1991. Intensive Care Med 20:542–549CrossRefPubMed
46.
Schmock GT, Meek PD, Ploetz PA, Vermeulen LC (1996) Economic evaluations of clinical pharmacy services-1988–1995. Pharmacotherapy 16:1188–1208
47.
Baldinger SL, Chow MSS, Gannon RH, Kelly ET (1997) Cost savings from having a clinical pharmacist work part-time in a medical intensive care unit. Am J Health-Syst Pharm 54:2811–2814
48.
Krupicka MI, Bratton SL, Sonnenthal K, Goldstein B (2002) Impact of a pediatric clinical pharmacist in the pediatric intensive care unit. Crit Care Med 30:919–921CrossRefPubMed
49.
Montazeri M, Cook DJ (1994) Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med 22:1044–1048CrossRefPubMed
50.
Miyagawa CI, Rivera JO (1986) Effect of pharmacist interventions on drug therapy costs in surgical intensive-care unit. Am J Hosp Pharm 43:3008–3013PubMed
51.
White CM, Chow MSS (1998) Cost impact and clinical benefits of focused rounding in the cardiovascular intensive care unit. Hosp Pharm 33:419–423
52.
Hurel D, Loirat P, Saulnier E, Nicolas F, Brivet F (1997) Quality of life 6 months after intensive care: results of a prospective multi-center study using a generic health status scale and satisfaction scale. Intensive Care Med 23:331–337CrossRefPubMed
53.
Schelling G, Stoll C, Haller M, Briegel J, Manert W, Hummel T, Lenhart A, Heyduck M, Polasek J, Meier M, Preuss U, Bullinger M, Schuffel W, Peter K (1998) Health-related quality of life and posttramatic stress disorder in survivors of the acute respiratory distress syndrome. Crit Care Med 26:651–659CrossRefPubMed
54.
Badia X, Diaz-Prieto A, Rue M, Patrick DL (1996) Measuring health and health state preferences among critically ill patients. Intensive Care Med 22:1379–1384CrossRefPubMed
55.
Chrispin PS, Scotton H, Lloyd RD, Lloyd D, Ridley SA (1997) Short form 36 in the intensive care unit: assessment of acceptability, reliability and validity of the questionnaire. Anaesthesia 52:15–23CrossRefPubMed
56.
Pickard AS, Johnson JA, Farris KB (1999) The impact of pharmacist interventions on health-related quality of life. Ann Pharmacotherapy 33:1167–1172CrossRef
57.
Bungay KM (2000) Methods to assess the humanistic outcomes of clinical pharmacy services. Pharmacotherapy 20:253S-258SCrossRefPubMed
58.
Devlin JW, Boleski G, Mlynarek M, Nerenx DR, Peterson E, Jankowski M, Horst HM, Zarowitz BJ (1999) Motor activity assessment scale: a valid and reliable sedation scale for use with mechanically ventilated patients in a surgical intensive care unit. Crit Care Med 27:1271–1275CrossRefPubMed
59.
Nelson BJ, Weinert CR, Bury CL, Marinelli WA, Gross CR (2000) Intensive care unit drug use and subsequent quality of life in acute lung injury patients. Crit Care Med 28:3626–3630CrossRefPubMed
60.
Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL (1997) Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general units. Crit Care Med 25:1289–1297CrossRefPubMed
61.
Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients. JAMA 279:1200–1205CrossRefPubMed
62.
Stratton TP, Wu B, Nakagawa RS (1993) Obtaining a critical care pharmacist position: a marketing case study. Can J Hosp Pharm 46:109–114PubMed
63.
Katona BG, Ayd PR, Walters JK, Caspi M, Finkelstein BW (1989) Effect of a pharmacist's and a nurse's interventions on cost of drug therapy in a medical intensive-care unit. Am J Hosp Pharm 46:1179–1182PubMed
Metadaten
Titel
The impact of critical care pharmacists on enhancing patient outcomes
verfasst von
Sandra L. Kane
Robert J. Weber
Joseph F. Dasta
Publikationsdatum
01.05.2003
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 5/2003
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-003-1705-3

Weitere Artikel der Ausgabe 5/2003

Intensive Care Medicine 5/2003 Zur Ausgabe

Original

RETRACTED ARTICLE: Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin

Original

Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock

Correspondence

Comment on "Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?" by P. Asfar

Original

Triaging patients to the ICU: a pilot study of factors influencing admission decisions and patient outcomes

Announcements

May 2003

Brief Report

A universal method for determining intensive care unit bed requirements

Neu im Fachgebiet AINS

Blutdrucksenkung schon im Rettungswagen bei akutem Schlaganfall?

31.05.2024 Apoplex Nachrichten

Der optimale Ansatz für die Blutdruckkontrolle bei Patientinnen und Patienten mit akutem Schlaganfall ist noch nicht gefunden. Ob sich eine frühzeitige Therapie der Hypertonie noch während des Transports in die Klinik lohnt, hat jetzt eine Studie aus China untersucht.

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise